Northwestern Medicine scientists have uncovered new findings about a protein called SET1B, which could offer a novel approach to treating triple-negative breast cancer.
Northwestern Medicine scientists identified a complex regulatory system that keeps cells functioning when their oxygen supply is cut off.
Mary McDermott, MD, ’92 GME, the Jeremiah Stamler Professor of Medicine and of Preventive Medicine, has been named a Distinguished Scientist by the American Heart Association (AHA).
A Northwestern Medicine clinical trial found that a stem cell therapy did not improve walking ability in people with peripheral artery disease, although exercise did lead to significant improvements.
Jacqueline Godbe, an MD/PhD student in the Medical Scientist Training Program and a champion triathlete, finds that training for races complements her studies.
The 7th Annual Les Turner Symposium showcased the integration of ALS investigation and clinical care at Northwestern Medicine and the Les Turner ALS Foundation.
New cross-cutting themes and a disease focus area were added to Feinberg’s research strategy, strengthening the vision for years to come.
Northwestern Medicine scientists have discovered that a protein called BRWD2/PHIP binds to H3K4 methylation, a key molecular event that influences gene expression.
Two Northwestern Medicine clinical trials investigated drugs to treat patients suffering from vasodilatory shock and respiratory failure, showing promising results.
Northwestern Medicine investigators applied discovery-based proteomics to identify synaptic protein interactions that possibly contribute to autism spectrum disorders.